The FIT-BI Project
Our project is funded by the European Union and the Horizon Europe MSCA Fellowship Program
Facing the urgent threat of antibiotic resistance
Our FIT-BI technology, funded by the European Union and the Horizon Europe Program, delivers rapid and multiplex bacterial identification and antimicrobial susceptibility predictions directly from clinical samples.
FIT-BI is the first point-of-care solution for rapid and multiplex bacterial identification
2.3 millions
babies died before turning one month in 2021
98% in LMICs
1. Rapid infection prediction
83% Sub-Saharan Africa & South Asia
2. Timely diagnosis
3. End preventable neonatal deaths
FIT-BI: Rapid results for a healthier tomorrow.
Real-time insights for predictive and precise treatment decisions, curbing unnecessary antibiotic use, and contributing to a sustainable future.
Learn how our H2020 Marie-Sklodowska-Curie funded project, in collaboration with BforCure, can revolutionize your diagnostic capabilities.
Let’s talk about your needs, book a slot here →
Once you book a meeting, we’ll automatically send you all the documentation you need to know everything about our processes, products and solutions.